세계 척추 비고정 장치 시장 규모는 2023년 11억 6,000만 달러, 2030년까지 16억 달러에 달할 것으로 예상되며, 2024-2030년의 예측 기간 동안 연평균 5.54% 성장할 것으로 예상됩니다. 척추 비고정 장치에 대한 수요는 주로 척추 질환의 유병률 증가, 노인 인구 증가, 척추 고정술에 비해 척추 비고정술의 장점, 제품 개발의 기술 혁신에 의해 주도되고 있습니다.
척추 비고정 장치 시장 역학
척추 비고정 장치 시장은 여러 가지 이유로 인해 제품 수요가 증가하고 있으며, 그 중 하나는 척추 질환의 유병률 증가로, Journal of Hospital Management and Health Policy에 발표된 Mattiuzzi 등의 'Current Epidemiology of Low Back Pain'에 따르면, 2020년 요통의 발병 건수, 유병률, 장애 조정 생존기간(DALYs)은 각각 연간 2억 4,590만 건(세계 15위), 5억 7,700만 건(세계 15위), 6,490만 DALYs(세계 6위)에 달할 전망입니다. 세계 6위)입니다. 이 신문은 또한 요통의 위험은 남성에 비해 여성이 약간 더 높다고 밝혔습니다. 만성 요통은 심각한 척추 질환이 기저에 있을 수 있는 가장 흔한 질환 중 하나입니다.
2018년 Global Spine Journal에 발표된 Ravindra 등의 'Degenerative Lumbar Spine Disease: Estimating Global Incidence and Worldwide' 조사에 따르면, 매년 약 2억 6,600만 명이 퇴행성 척추질환으로 고통받고 있습니다. 6,600만 명이 퇴행성 척추 질환과 요통으로 고통받고 있습니다. 이 데이터는 또한 매년 4억 3천만 명이 증상성 추간판 퇴행성 질환, 1억 3천만 명이 척추관 협착증, 3,900만 명이 척추 전방전위증을 앓고 있다고 언급하고 있습니다.
위의 정보는 추간판 퇴행성 질환, 추간판 탈출증, 요통과 같은 다양한 척추 질환의 유병률과 이환율이 증가하고 있음을 보여줍니다. 또한, 추간판탈출증과 퇴행성 질환으로 인한 추간판 손상은 퇴행성 질환의 가속화와 만성 통증의 장기화와 같은 합병증을 유발하는 것으로 알려져 있습니다. 척추 질환은 환자의 삶의 질에 큰 영향을 미치기 때문에 이러한 적응증은 중요한 치료법 중 하나로 수술적 개입이 필요합니다.
척추 비고정 장치는 비고정적 접근을 통해 척추의 해부학적 수술적 결함을 교정하는 의료기기입니다. 기존의 척추 고정술에 비해 비고정 척추 수술은 의사와 환자들 사이에서 많은 지지를 받고 있습니다. 척추 고정술은 수많은 척추 질환 치료의 표준으로 여겨지지만, 인접한 척추뼈의 퇴행이 가속화되는 것과 관련이 있으며, 하나 이상의 척추 고정술은 척추의 경직과 운동성 저하를 유발합니다.
따라서 시장에서는 척추 비고정 제품에 대한 수요가 증가하고 있습니다. 척추 비고정 장치는 이동성 보존 장치라고도 합니다. 이러한 장치는 기능적 척추 단위의 이동성을 유지하면서 안정화를 가져오고 통증을 제거하도록 설계되었기 때문에 인기가 높아지고 있습니다. 이러한 시스템 및 장치는 척추의 자연 구조를 유지하면서 적응증을 치료합니다.
그러나 대체 제품의 가용성 및 채택 지연은 척추 비고정 장치 시장의 성장을 저해하는 요인으로 작용할 수 있습니다.
척추 비고정 장치 시장 부문별 분석
척추 비고정 장치 시장의 제품 부문에서는 동적 안정화 장치가 예측 기간 동안 척추 비고정 장치 시장에서 큰 점유율을 차지할 것으로 예상됩니다. 동적 안정화는 관절의 이동성을 유지하면서 척추의 전방 및 후방 요소에 체중을 분산시켜 통증을 없애는 것을 목표로 합니다. 현재 척추의 동적 안정화를 위해 다양한 새로운 장치가 개발되고 있습니다. 척추의 동적 안정화는 인접한 추간판과 소면체 관절의 부하를 줄이고 인접한 분절의 이동성을 유지할 수 있어 고정 부위에 인접한 추간판의 퇴행 등 금속 임플란트 특유의 문제를 줄일 수 있어 척추 수술의 성장 분야로 떠오르고 있습니다.
이 보고서는 세계 척추 비고정 장치 시장에 대해 조사 분석했으며, 시장 규모와 예측, 촉진요인 및 과제, 기업 및 제품 프로파일 등의 정보를 전해드립니다.
Spinal Non Fusion Devices Market By Product Type (Artificial Disc [Lumbar and Cervical], Dynamic Stabilization Devices, Facet Replacement Products, and Others), Spinal Non Fusion Devices By Application (Spinal Stenosis, Degenerative Disc Diseases, Spondylolisthesis, and Others), Spinal Non Fusion Devices By End User (Hospitals, Specialty Clinics, and Others), and Spinal Non Fusion Devices By Geography is expected to grow at a steady CAGR (forecast period- 2024-2030) owing to increasing prevalence of spinal disorders and advantages of spinal non fusion procedures.
Global Spinal Non Fusion Devices Market was valued at USD 1.16 billion in 2023, growing at a CAGR of 5.54% during the forecast period from 2024 to 2030 to reach USD 1.60 billion by 2030. The demand for spinal non fusion devices is primarily being boosted by rising prevalence of spinal disorders, growing geriatric population base, advantages of spinal non fusion procedures over fusion procedures, and technical innovation in product development.
Spinal Non Fusion Devices Market Dynamics:
The spinal non fusion devices market is witnessing a growth in product demand due to various reasons, one of them being the rising prevalence of spinal disorders. According to the research published in the Journal of Hospital Management and Health Policy, titled "Current Epidemiology of Low Back Pain" by Mattiuzzi et al, in 2020, incidence, prevalence and disability-adjusted life years (DALYs) of LBPs are 245.9 million cases per year (15th worldwide cause), 577.0 million cases (15th worldwide cause) and 64.9 million DALYs (6th worldwide cause), respectively. The paper further stated that the risk of LBP is marginally higher in women compared to men. Chronic lower back pain is one of the commonest complaint that may point towards an underlying serious spinal disorder.
As per the research published in the Global Spine Journal, titled "Degenerative Lumbar Spine Disease: Estimating Global Incidence and Worldwide" by Ravindra et al published in 2018, approximately 266 million individuals suffered from degenerative spinal disease and lower back pain each year. The data further mentioned that 403 million presented with symptomatic disc degeneration, 103 million with spinal stenosis, and 39 million with spondylolisthesis annually.
The abovementioned facts indicate toward the growing prevalence and incidence various spinal disorders such as degenerative disc disease, disc herniation, and back pain among others. Moreover, it has been observed that annulus fibrosus injury from herniation and degeneration can result in complications such as accelerated degeneration and prolonged chronic pain. As spinal disorders can majorly impact the quality of life of patients, these indications require surgical interventions as one of the key treatment methods.
Non fusion spinal devices are medical devices which are employed in the correction of anatomical surgical defects of the spine using a non-fusion approach. Compared to conventional spinal fusion surgeries, non-fusion spinal surgeries are gaining traction among doctors and patients. Even though spinal fusion is considered the "gold-standard" for the treatment of numerous spinal disorders, it is associated with the accelerated degeneration of the vertebrae of the adjacent levels. A spinal fusion at one or more levels causes stiffness and decreased motion of the spin
Therefore, there has been a growing demand for spinal non-fusion products in the market. Spinal non-fusion devices are also known as motion-preserving devices. These devices are gaining popularity as these devices are designed with the intent to providing stabilization and eliminate pain while preserving motion of the functional spinal unit. These systems and devices treat the indication while maintaining the natural structural of the spine.
However, availability of alternative products and slow adoption may be certain impeding factors to the spinal non fusion devices market growth.
Spinal Non Fusion Devices Market Segment Analysis:
Spinal Non Fusion Devices market by Product (Artificial Disc [Lumbar and Cervical], Dynamic Stabilization Devices, Facet Replacement Products, and Others), Spinal Non Fusion Devices Market By Application (Spinal Stenosis, Degenerative Disc Diseases, Spondylolisthesis, and Others), Spinal Non Fusion Devices market by End User (Hospitals, Specialty Clinics, and Others), and Spinal Non Fusion Devices market by Geography (North America, Europe, Asia-Pacific, and Rest of the World).
In the product segment of the Spinal Non Fusion Devices Market, the dynamic stabilization devices are expected to hold a significant share in the spinal non fusion devices market in the forecast period. While trying to maintain the motion in the joint, dynamic stabilization aims to remove the pain by distributing the weight between anterior and posterior elements of the spine. Various new devices have now been developed for the dynamic stabilization of the spine. Dynamic spine stabilization is a growing area of spine surgery because it can reduce some of the problems inherent with metal implants, such as disc degeneration in the discs next to the fusion site as they allow for less loading on the adjacent discs and facet joints and preserve adjacent segmental motion.
Dynamic stabilization makes use of rods made of flexible materials to provide stability to the affected level of the spine. Thus, the versatility of dynamic stabilization devices to be either used alone or in combination with fusion procedures further add to their market demand.
Non spinal fusion dynamic stabilization devices are further classified into pedicle screw-based systems, interspinous process spacers, and facet replacement products, and others. Among these, pedicle-screw systems are predicted to hold the significant market share in the forecast period in spinal non fusion devices market.
Therefore, the constant technological advancements coupled with added advantages and product versatility of dynamic stabilization devices among other product types is expected to boost the growth of the spinal non fusion devices market. For instance, in June 2022, Neo Medical received FDA 510(k) clearance for their Pedicle Screw System in the treatment of late stage tumor indications to be used in combination with BonOs® Inject cement from OSARTIS. The company also received the CE mark approval for the same device. In another development, Centinel Spine, LLC launched the Angled Endplate implants for the prodisc® L Lumbar Total Disc Replacement System which have been designed to shift the lordotic angle of the implant to the inferior endplate thereby allowing surgeons to address he varied lumbar anatomy and pathology of patients.
North America Is Expected To Dominate The Overall Spinal Non Fusion Devices Market:
Among all the regions, North America is expected to account for the largest share in the spinal non fusion devices market. Owing to significant growth factors such as rising prevalence of geriatric population, increasing incidences of spinal disorders, rising government initiatives, and increased government product regulations are expected to aid in the growth of the North American Spinal Non Fusion Devices Market. Furthermore, high disposable income, sophisticated healthcare infrastructure, new product approvals, and increased awareness also propelled the market growth in this region.
As per the data provided by the United States Bone and Joint Initiative (2023), musculoskeletal diseases affect more than one out of every two persons in the United States age 18 and over, and nearly three out of four age 65 and over. Trauma, back pain, and arthritis are the three most common musculoskeletal conditions reported, and for which health care visits to physicians' offices, emergency departments, and hospitals occur each year. Furthermore, the abovementioned source stated that in any given year, 12% to 14% of the adult population will visit their physician for back pain.
Moreover, the presence of a well-regulated reimbursement channel for spine surgeries and the healthcare facilities are further expected to drive the North American Spinal Non Fusion Devices market forward.
The fastest growth in the Spinal Non Fusion Devices market is expected to be witnessed by the Asia-Pacific on account of improving disposable income, increasing focus on improving healthcare access among populations, which in turn is motivating key spinal non fusion market players in widening their market reach in the APAC region.
Spinal Non Fusion Devices Market Key Players:
Some of the key market players operating in the spinal non fusion devices market includes Stryker, NuVasive Inc, Medtronic, Zimmer Biomet, ATEC Spine, Inc, B. Braun Melsungen, SIGNUS Medizintechnik GmbH, Aditus Medical, RTI Surgical, Orthofix Medical Inc, Premia Spine, Globus Medical, SpineSave AG, Centinel Spine®, LLC, AxioMed LLC., Spinal Stabilization Technologies Ltd, SpineVision, Norm Medical Devices Co. Ltd., Neuro France Implants, Ackermann Medical GmbH & Co. KG and others.
Recent Developmental Activities in Spinal Non Fusion Devices Market:
In August 2022, Orthofix Medical Inc announced the first patient implant in the M6-C Artificial Cervical Disc Two-Level investigation device exemption (IDE) Study. The M6-C artificial cervical disc was FDA-approved for single-level implantation from C3 to C7 in 2019. It is indicated as an alternative to cervical fusion.
In May 2022, Spinal Stabilization Technologies Ltd received the Breakthrough Designation for PerQ disc Nucleus Replacement System for degenerative disc disease. The device also received the CE mark approval. PerQdisc is the only commercially available lumbar nucleus replacement system in the world.
In April 2022, NuVasive Inc received the 510k approval from the US FDA for their two-level cervical total disc replacement- Simplify Disc.
Key Takeaways from the Spinal Non Fusion Devices Market Report Study
Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the spinal non fusion devices market.
Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
Key companies dominating the Global Spinal Non Fusion Devices Market.
Various opportunities available for the other competitor in the Spinal Non Fusion Devices Market space.
What are the top performing segments in 2023? How these segments will perform in 2030?
Which is the top-performing regions and countries in the current spinal non fusion devices market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for spinal non fusion devices market growth in the coming future?
Target Audience who can be benefited from this Spinal Non Fusion Devices Market Report Study
Spinal Non Fusion Devices products providers
Research organizations and consulting companies
Spinal Non Fusion Devices-related organization, association, forum, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders dealing in spinal non fusion devices
Various End-users who want to know more about the Spinal Non Fusion Devices market and latest technological developments in the Spinal Non Fusion Devices market.
Frequently Asked Questions for Spinal Non Fusion Devices Market:
Non fusion spinal devices are medical devices which are employed in the correction of anatomical surgical defects of the spine using a non-fusion approach.
Global Spinal Non Fusion Devices Market was valued at USD 1.16 billion in 2023, growing at a CAGR of 5.54% during the forecast period from 2024 to 2030 to reach USD 1.60 billion by 2030.
The demand for spinal non fusion devices is primarily being boosted by rising prevalence of spinal disorders, growing geriatric population base, advantages of spinal non fusion devices over fusion devices, and technical innovation in product development.
Some of the key market players operating in the spinal non fusion devices market includes Stryker, NuVasive Inc, Medtronic, Zimmer Biomet, ATEC Spine, Inc, B. Braun Melsungen, Advanced Brain Monitoring, Inc, BrainScope Company Inc SIGNUS Medizintechnik GmbH, Aditus Medical, RTI Surgical, Orthofix Medical Inc, Premia Spine, Globus Medical, SpineSave AG, Centinel Spine®, LLC, AxioMed LLC., Spinal Stabilization Technologies Ltd, SpineVision, Norm Medical Devices Co. Ltd. and, Neuro France Implants, Ackermann Medical GmbH & Co. KG and others.
North America is expected to dominate the overall Spinal Non Fusion Devices market during the forecast period, 2024 to 2030. The high revenue domination across regions by North America can be ascribed to significant growth factors such as rising prevalence of geriatric population, increasing incidences of spinal disorders, rising government initiatives, and increased government product regulations are expected to aid in the growth of the North American Spinal Non Fusion Devices Market. Furthermore, high disposable income, sophisticated healthcare infrastructure, new product approvals, and increased awareness also propelled the market growth in this region.